SCI Abstract

search
+
Accuracy of carbohydrate‐deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism
Accuracy of carbohydrate‐deficient transferrin as a biomarker of chronic alcohol abuse during treatment for alcoholism
Abstract Aim Clinical evaluations are generally used to verify the effectiveness of detoxification treatments for alcohol ...
Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma
Identification of microRNA‐96‐5p as a postoperative, prognostic microRNA predictor in nonviral hepatocellular carcinoma
Abstract Aim The microRNA (miR) clusters miR-183/96/182 and miR-217/216a/216b are significantly upregulated in nonviral he...
Can microRNA‐96‐5p serve as a therapeutic molecule in the near future?
Can microRNA‐96‐5p serve as a therapeutic molecule in the near future?
Volume 52, Issue 1 p. 3-4 EDITORIAL Tsutomu Masaki, Corresponding Author ...
Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)
Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)
Abstract In the 22nd Nationwide Follow-up Survey of Primary Liver Cancer in Japan, data from 21 155 newly registere...
Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis
Ratio of von Willebrand factor antigen to ADAMTS13 activity is a useful biomarker for acute‐on‐chronic liver failure development and prognosis in patients with liver cirrhosis
Abstract Aim Acute-on-chronic liver failure (ACLF) is associated with a high risk of short-term mortality after progressio...
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
Hyperprogressive disease in patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy
Abstract Background Atezolizumab plus bevacizumab was approved for hepatocellular carcinoma (HCC) patients in 2020, but tr...
ATF2 accelerates the invasion and metastasis of hepatocellular carcinoma through targeting the miR‐548p/TUFT1 axis
ATF2 accelerates the invasion and metastasis of hepatocellular carcinoma through targeting the miR‐548p/TUFT1 axis
AbstractAimDue to high invasion and metastasis, hepatocellular carcinoma is known as one of the most fatal carcinomas. We ...
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis
Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis
Abstract Aim Direct-acting antivirals (DAAs) are currently available even for patients with decompensated cirrhosis. Repor...
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis
Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysis
Abstract Background/Aim Although systemic therapy is recommended for patients with multiple intermediate stage unresectabl...
Factors associated with portopulmonary hypertension
Factors associated with portopulmonary hypertension
PDF ShareShare Please review our Terms and Conditions of Use...
Is it necessary to revise the liver transplantation guidelines to meet the current situation?
Is it necessary to revise the liver transplantation guidelines to meet the current situation?
Volume 51, Issue 12 p. 1177-1178 EDITORIAL Takeshi Matsui, Corresponding Author ...
Unexpected hepatitis B virus transmission after liver transplant from nucleic acid testing‐ and serology‐negative liver donors who are hepatitis C viremic
Unexpected hepatitis B virus transmission after liver transplant from nucleic acid testing‐ and serology‐negative liver donors who are hepatitis C viremic
Abstract The opioid epidemic has led to increased availability of organs for liver transplantation. The success of direct-...
Comparison of diagnostic performance between FIB‐4 and NFS in metabolic‐associated fatty liver disease era
Comparison of diagnostic performance between FIB‐4 and NFS in metabolic‐associated fatty liver disease era
AbstractAimsFibrosis-4 index (FIB-4) and non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS) are the two most w...
Screening for portopulmonary hypertension using computed tomography‐based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension
Screening for portopulmonary hypertension using computed tomography‐based measurements of the main pulmonary artery and ascending aorta diameters in patients with portal hypertension
ABSTRACT Aim This study aimed to demonstrate the feasibility of identifying candidates of portopulmonary hypertension (PoP...
Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen®, for people living with HIV
Predictors associated with a better response to the Japanese aluminum‐free hepatitis A vaccine, Aimmugen®, for people living with HIV
Abstract Aim After the hepatitis A virus (HAV) outbreak among men who have sex with men (MSM) around 2018, the importance ...
format_indent_increase